Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bengbu Fengyuan Tushan Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of Anhui Fengyuan Pharmaceutical. Based in Bengbu, Anhui Province, the company specializes in the production of active pharmaceutical ingredients (APIs) and finished dosage forms across several therapeutic categories, including antipyretic analgesics, cardiovascular drugs, and anti-infectives. The company is well-known for its large-scale production of essential medicines such as paracetamol, metformin, and aspirin. Operating under strict GMP standards, it serves both the domestic Chinese healthcare market and international export markets. Its facilities include advanced production lines for tablets, capsules, and chemical synthesis of APIs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bengbu Fengyuan Tushan Pharmaceutical.